RxDoctor Payments Data

Jenni McCann

Psychiatric/Mental Health · Dubuque, IANPI 1891371944

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 260 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations.

$4,064in general payments, 2019–2025

Across 260 payments — averaging $15.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$690
  • Axsome Therapeutics, Inc.$481
  • Supernus Pharmaceuticals, Inc.$440
  • Lundbeck LLC$372
  • Johnson & Johnson$338
  • Otsuka America Pharmaceutical, Inc.$329
  • plus $1K from 10 others

What the payments were for

  • Food & beverage$4,064100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,064 in reported general payments places this provider in the 85th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$11,191
Medicare patients
34
Services billed
136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Paliperidone ErPaliperidone26$7,732
Naltrexone Hcl38$3,559
Buspirone Hcl146$2,460
Divalproex Sodium ErDivalproex Sodium53$1,478
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine23$1,456
Guanfacine Hcl38$1,217
Escitalopram Oxalate64$1,205
Risperidone52$1,176
Venlafaxine Hcl ErVenlafaxine Hcl35$849
Quetiapine Fumarate68$833
Prazosin Hcl58$815
Aripiprazole47$810
Duloxetine Hcl86$737
Clonazepam105$653
Trazodone Hcl85$593

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Dubuque

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →